Ally Bridge Group (NY) LLC
An institutional investment manager in NEW YORK, NY. Its Form 13F for the quarter ended Jun 30, 2026, filed Aug 14, 2026. SEC CIK 1822947.
- Reported value$113.1m
- Positions25
Holdings: 25 positions
The filing on sec.govAs filed, largest first. Reported value is what the manager stated for each position at the quarter end, in US dollars; it is filing data, not a price. Weight is the position's share of the total reported value. Changes compare with the 13F for the quarter ended 2026-03-31.
| Issuer | Class | CUSIP | Reported value$m | Weight | Shares | Put or call | Change on the quarter before |
|---|---|---|---|---|---|---|---|
| Definium Therapeutics IncDFTX | COM SHS | 24477V105 | 18.8 | 16.6% | 400,000 | Call | New+400,000 |
| Abivax SAABVX | SPONSORED ADS | 00370M103 | 16.7 | 14.7% | 125,000 | Call | New+125,000 |
| Minerva Neurosciences IncNERV | COM NEW | 603380205 | 12.1 | 10.7% | 2,175,802 | Added+520,302 | |
| Promis Neurosciences IncPMN | COM SHS | 74346M505 | 8.2 | 7.2% | 620,319 | Added+206,100 | |
| First Tracks BiotherapeuticsTRAX | ORD SHS | 337185102 | 5.7 | 5.1% | 284,287 | New+284,287 | |
| Axsome Therapeutics IncAXSM | COM | 05464T104 | 4.0 | 3.6% | 16,493 | New+16,493 | |
| Assembly Biosciences IncASMB | COM NEW | 045396207 | 3.8 | 3.4% | 140,000 | New+140,000 | |
| Whitehawk Therapeutics IncWHWK | COM | 00032Q104 | 3.7 | 3.3% | 817,939 | Unchanged | |
| Edgewise Therapeutics IncEWTX | COM | 28036F105 | 3.4 | 3.0% | 83,300 | Reduced−77,700 | |
| Climb Bio IncCLYM | COM | 28658R106 | 3.2 | 2.9% | 249,172 | New+249,172 | |
| Kura Oncology IncKURA | COM | 50127T109 | 3.2 | 2.8% | 290,000 | New+290,000 | |
| Cytomx Therapeutics Inc.CTMX | COM | 23284F105 | 2.9 | 2.6% | 775,000 | Reduced−125,000 | |
| Avalo Therapeutics IncAVTX | SPONSORED ADS | 05338F306 | 2.8 | 2.5% | 150,000 | New+150,000 | |
| Palisade Bio IncPALI | COM | 696389402 | 2.6 | 2.3% | 1,229,000 | New+1,229,000 | |
| Solid Biosciences IncSLDB | COM | 83422E204 | 2.6 | 2.3% | 255,959 | Reduced−511,015 | |
| AN2 Therapeutics IncANTX | COM | 037326105 | 2.5 | 2.3% | 526,315 | Unchanged | |
| Urogen Pharma Ltd | COM | M96088105 | 2.5 | 2.3% | 69,183 | Reduced−132,941 | |
| Perspective Therapeutics IncCATX | COM NEW | 46489V302 | 2.5 | 2.2% | 743,958 | Reduced−182,599 | |
| Ideaya Biosciences IncIDYA | COM | 45166A102 | 2.5 | 2.2% | 67,500 | New+67,500 | |
| Inventiva SAIVA | ADS | 46124U107 | 2.4 | 2.1% | 634,800 | Reduced−110,500 | |
| Alumis IncALMS | COM | 022307102 | 2.2 | 1.9% | 76,459 | Reduced−90,500 | |
| Ovid Therapeutics IncOVID | COM | 690469101 | 1.7 | 1.5% | 624,561 | Reduced−2,193,898 | |
| Eupraxia Pharmaceuticals IncEPRX | COM | 29842P105 | 1.7 | 1.5% | 252,175 | Reduced−408,200 | |
| Ibio IncIBIO | COM NEW | 451033708 | 0.7 | 0.6% | 390,147 | New+390,147 | |
| Traws Pharma IncTRAW | COM | 68232V884 | 0.7 | 0.6% | 786,236 | New+786,236 |
Sold out: 14 positions
Held at the end of the quarter before and not reported this quarter.
| Issuer | Class | CUSIP | Reported value$ | Weight | Shares | Put or call | Change on the quarter before |
|---|---|---|---|---|---|---|---|
| Abivax SAABVX | SPONSORED ADS | 00370M103 | 0.0 | 0.0% | 0 | Sold out−33,712 | |
| Capricor Therapeutics IncCAPR | COM NEW | 14070B309 | 0.0 | 0.0% | 0 | Sold out−113,899 | |
| Compass Pathways plcCMPS | SPONSORED ADS | 20451W101 | 0.0 | 0.0% | 0 | Sold out−1,045,000 | |
| Compass Therapeutics IncCMPX | COM | 20454B104 | 0.0 | 0.0% | 0 | Call | Sold out−1,000,000 |
| Inhibikase Therapeutics IncIKT | COM NEW | 45719W205 | 0.0 | 0.0% | 0 | Sold out−1,325,000 | |
| Karyopharm Therapeutics IncKPTI | COM NEW | 48576U205 | 0.0 | 0.0% | 0 | Call | Sold out−250,000 |
| Maze Therapeutics IncMAZE | COM | 578784100 | 0.0 | 0.0% | 0 | Call | Sold out−100,000 |
| Praxis Precision Medicines IPRAX | COM NEW | 74006W207 | 0.0 | 0.0% | 0 | Sold out−32,810 | |
| Relmada Therapeutics IncRLMD | COM | 75955J402 | 0.0 | 0.0% | 0 | Sold out−210,525 | |
| Replimune Group IncREPL | COM | 76029N106 | 0.0 | 0.0% | 0 | Call | Sold out−246,900 |
| Soleno Therapeutics Inc | COM | 834203309 | 0.0 | 0.0% | 0 | Put | Sold out−200,000 |
| Soleno Therapeutics Inc | COM | 834203309 | 0.0 | 0.0% | 0 | Sold out−200,000 | |
| Tarsus Pharmaceuticals IncTARS | COM | 87650L103 | 0.0 | 0.0% | 0 | Sold out−80,859 | |
| Uniqure NV | SHS | N90064101 | 0.0 | 0.0% | 0 | Call | Sold out−300,000 |
Source: SEC EDGAR, Form 13F-HR, accession 0001193125-26-352338 (on sec.gov). Last ingested by Listed: Oct 22, 2026, 05:26 ET. Listed shows no prices and gives no investment advice.